S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 11.88 CNY -5.64% Market Closed
Market Cap: 7.8B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Shandong Sinobioway Biomedicine Co Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Sinobioway Biomedicine Co Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Tax Provision
-ÂĄ10.9m
CAGR 3-Years
8%
CAGR 5-Years
-14%
CAGR 10-Years
6%
Fufeng Group Ltd
HKEX:546
Tax Provision
-ÂĄ673.3m
CAGR 3-Years
-58%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
G
GHW International
HKEX:9933
Tax Provision
ÂĄ9.5m
CAGR 3-Years
85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
Tax Provision
-ÂĄ1.1B
CAGR 3-Years
-3%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Zhejiang XinAn Chemical Industrial Group Co Ltd
SSE:600596
Tax Provision
-ÂĄ81.1m
CAGR 3-Years
33%
CAGR 5-Years
-28%
CAGR 10-Years
-5%
A
Anhui Jinhe Industrial Co Ltd
SZSE:002597
Tax Provision
-ÂĄ68.7m
CAGR 3-Years
24%
CAGR 5-Years
11%
CAGR 10-Years
-10%
No Stocks Found

Shandong Sinobioway Biomedicine Co Ltd
Glance View

Market Cap
7.8B CNY
Industry
Chemicals

Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 653 full-time employees. The company went IPO on 2011-05-20. The firm's main products include encyclopedia, anferon, triethyl orthoformate, trimethyl orthofomate, trimethyl orthoacetate and related secondary products, among others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
3.08 CNY
Overvaluation 74%
Intrinsic Value
Price
S

See Also

What is Shandong Sinobioway Biomedicine Co Ltd's Tax Provision?
Tax Provision
-10.9m CNY

Based on the financial report for Jun 30, 2024, Shandong Sinobioway Biomedicine Co Ltd's Tax Provision amounts to -10.9m CNY.

What is Shandong Sinobioway Biomedicine Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
6%

Over the last year, the Tax Provision growth was -29%. The average annual Tax Provision growth rates for Shandong Sinobioway Biomedicine Co Ltd have been 8% over the past three years , -14% over the past five years , and 6% over the past ten years .

Back to Top